Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Buspirone D3 Receptor Occupancy PET Study
NCT01699828Phase 2Completed
- Sponsor
- Center for Addiction and Mental Health
- Start
- Oct 2012
- Primary completion
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of buspirone in Tobacco Use Disorder (TUD), sponsored by Center for Addiction and Mental Health. Started Oct 2012; status: completed.
02
Drugs
buspirone
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT01699828.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01699828.